We served as lead regulatory counsel to a private equity investment firm in its multi-billion dollar bid to take a publicly traded healthcare company private. Our team conducted regulatory due diligence and advised the private equity investment firm on the deal.
Private Equity Firm Takes Public Company Private
You Also May Be Interested In:
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Representation of LogistiCare in its $80 million acquisition of National MedTrans, a single source Non-Emergency Medical Transportation (NEMT) benefit management company focused on delivering services to managed care organizations and governmental entities throughout the United States, as well as the extension of its revolving credit facilities from $200 million to $225 million
Representation of Spring Fertility, a leading provider of fertility care in Northern California backed by Wildcat Capital, in its acquisition of Genesis Fertility Centre, a Vancouver, British Columbia-based fertility clinic